Drawing for BIODRIVER

USPTO serial 85349816

BIODRIVER

Reviewed by CopyMark Law Group

Reg. 4692711Status 710
Filing date
Status date
Registration date
Feb 24, 2015
Examiner
THOMAS, JANICE
Law office
TMEG LAW OFFICE 103

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIODRIVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Assays and reagents for use in genetic research; Biochemicals, namely, precursors for in vitro genetic engineering use; Genetic identity tests comprised of reagentsSECTION 8 - CANCELLEDJan 1, 2015
005[ Gene therapy products, namely, genetically engineered tissues for transplant purposes; Preparations for detecting genetic predispositions for medical purposes ]SECTION 7(e) - CANCELLEDJan 1, 2015
009Electrical equipment for the genetic modification of cells for research purposes; Laboratory devices for detecting genetic sequencesSECTION 8 - CANCELLEDJan 1, 2015
010[ Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; Medical device for detecting cancer; Medical device for treating cancer; Medical device for treating lymphedema; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical device, namely, a remote manipulation system consisting of a robotic arm, knob, deflection lever, and buttons, to facilitate remote catheterizations; Medical device, namely, a tele-robotic system consisting of a motorized catheter positioner having rotational and translational movement capability and a tele-robotic controller with rotation, translation and deflection control buttons, to facilitate remote catheterizations; Medical devices for nonsurgical cosmetic treatments; Medical devices for treating congestive heart failure; Medical devices to treat intravascular sites; Medical devices, namely, devices for spinal disc repair in the nature of an apparatus used in spinal disc repair procedures; Medical devices, namely, minimally invasive neurovascular devices for the treatment of neurological conditions; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues ]SECTION 7(e) - CANCELLEDJan 1, 2015
042[ Conducting research and clinical trials relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Genetic mapping for scientific purposes; Genetic testing of laboratory animals for research purposes; Providing a website featuring information about investigational medical devices, diagnostic and drugs; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy ]SECTION 7(e) - CANCELLEDJan 1, 2015
044[ Genetic testing for medical purposes; Genetic testing of animals ]SECTION 7(e) - CANCELLEDJan 1, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2021C8..CANCELLED SEC. 8 (6-YR)—
Feb 24, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 3, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 27, 2015C7P.CANCELLED SEC. 7 - PARTIAL—
Nov 27, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 16, 2015C7PFRQST FOR SECT 7 PARTIAL SURRENDER FILED—
Nov 16, 2015ES7STEAS SECTION 7 SURRENDER RECEIVED—
Feb 24, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 23, 2015SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 22, 2015CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 20, 2015SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 3, 2015IUAFUSE AMENDMENT FILED—
Jan 3, 2015EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 8, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 7, 2014EX5GSOU EXTENSION 5 GRANTED—
Jul 1, 2014EXT5SOU EXTENSION 5 FILED—
Jul 1, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 13, 2014EX4GSOU EXTENSION 4 GRANTED—
Dec 31, 2013EXT4SOU EXTENSION 4 FILED—
Dec 31, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2013EX3GSOU EXTENSION 3 GRANTED—
Jul 26, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 1, 2013EXT3SOU EXTENSION 3 FILED—
Jul 1, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2013ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 9, 2013EX2GSOU EXTENSION 2 GRANTED—
Jan 2, 2013EXT2SOU EXTENSION 2 FILED—
Jan 2, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 2, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 30, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 28, 2012EX1GSOU EXTENSION 1 GRANTED—
Jun 28, 2012EXT1SOU EXTENSION 1 FILED—
Jun 28, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 3, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 8, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 8, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 28, 2011DOCKASSIGNED TO EXAMINER—
Jun 23, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Jun 22, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 22, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance